brainstorm cell therapeutics and als

Search results

- Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript
  Insider Monkey via Yahoo Finance· 5 months ago
  Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript November 14, 2023...
- BrainStorm, after setbacks, withdraws approval application for ALS drug
  BioPharma Dive via Yahoo Finance· 6 months ago
  A panel of FDA advisers last month found BrainStorm’s data unconvincing. The company now says a...
- FDA staff reviewers raise concerns over BrainStorm Cell's ALS therapy (Sept 25)
  Reuters via AOL· 7 months ago
  The U.S. Food and Drug Administration's staff reviewers raised concerns on Monday over the safety...
- FDA Refuses To Accept BrainStorm Cell's Lead Candidate For Amyotrophic Lateral Sclerosis
  Benzinga via Yahoo Finance· 1 year ago
  BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) received a refusal to file letter from the FDA...
- Q2 2023 Brainstorm Cell Therapeutics Inc Earnings Call
  Thomson Reuters StreetEvents via Yahoo Finance· 8 months ago
  Participants Chaim Lebovits; President & CEO; Brainstorm Cell Therapeutics Inc. Stacy Lindborg; Co-CEO; Brainstorm Cell Therapeutics Inc. Alla Patlis; Interim CFO; Brainstorm Cell Therapeutics ...
- FDA advisers vote against experimental ALS treatment pushed by patients
  Associated Press via Yahoo News· 7 months ago
  Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig’s...
- US FDA panel votes against BrainStorm's ALS therapy over effectiveness concern
  Reuters via AOL· 7 months ago
  (Reuters) -Advisers to the U.S. health regulator on Wednesday voted against BrainStorm Cell Therapeutics' therapy for a rare and fatal neurodegenerative disease called amyotrophic lateral sclerosis ...
- Biotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More
  Zacks via Yahoo Finance· 1 year ago
  Drug approvals and other regulatory news are in focus in the biotech sector. Updates on booster...
- US FDA panel votes against BrainStorm's ALS therapy
  Reuters via Yahoo Finance· 7 months ago
  Sept 27 (Reuters) - The U.S. health regulator's advisers on Wednesday voted against BrainStorm Cell Therapeutics' therapy for patients with amyotrophic lateral sclerosis (ALS), a neurodegenerative ...
- NIH to fund unproven ALS drugs under patient-backed law
  Associated Press via Yahoo News· 2 years ago
  When patients with a deadly diagnosis and few treatment options have tried to get unapproved,...